Abbott Laboratories/ US0028241000 /
| 2024-04-18 5:40:55 PM | Chg. -0.57 | Volume | Bid5:41:15 PM | Ask5:41:15 PM | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 105.29USD | -0.54% | 61,192 Turnover: 6.48 mill. |
104.63Bid Size: 114 | 115.69Ask Size: 100 | 183.3 bill.USD | 1.97% | 32.21 |
Assets
|
2010 US GAAP in mill. USD |
2011 US GAAP in mill. USD |
2012 US GAAP in mill. USD |
2013 US GAAP in mill. USD |
2014 US GAAP in mill. USD |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Property and Equipment | 7,971 | 7,874 | 8,063 | 5,905 | 5,935 | ||||||
| Intangible Assets | 12,151.6000 | 9,989.6000 | 8,588.3000 | 5,735 | 6,198 | ||||||
| Long-Term Investments | 302 | 378.2000 | 273.6000 | 119 | 229 | ||||||
| Fixed Assets | - | - | - | - | 26,014 | ||||||
| Inventories | 3,188.7000 | 3,284.2000 | 3,792.3000 | 2,693 | 2,643 | ||||||
| Accounts Receivable | 7,184 | 7,683.9000 | 7,612.9000 | 3,986 | 3,586 | ||||||
| Cash and Cash Equivalents | 3,648.4000 | 6,812.8000 | 10,802.2000 | 3,475 | 4,063 | ||||||
| Current Assets | 22,317.5000 | 23,768.8000 | 31,322.6000 | 19,247 | 15,261 | ||||||
| Total Assets | 59,462.3000 | 60,276.9000 | 67,234.9000 | 42,953 | 41,275 | ||||||
Liabilities
|
2010 US GAAP in mill. USD |
2011 US GAAP in mill. USD |
2012 US GAAP in mill. USD |
2013 US GAAP in mill. USD |
2014 US GAAP in mill. USD |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 1,535.8000 | 1,721.1000 | 1,797 | 1,026 | 1,064 | ||||||
| Long-term debt | - | - | - | - | 3,408 | ||||||
| Liabilities to Banks | 4,349.8000 | 2,347.9000 | 2,081.8000 | 3,164 | 4,382 | ||||||
| Provisions | 1,307.7000 | 514.9000 | 655.4000 | 175 | 270 | ||||||
| Liabilities | 36,985.8000 | 35,750.7000 | 40,421.7000 | 17,686 | 19,636 | ||||||
| Share Capital | - | - | - | - | 12,383 | ||||||
| Total Equity | 22,476.5000 | 24,526.1000 | 26,813.2000 | 25,267 | 21,639 | ||||||
| Minority Interests | 88.3000 | 86.3000 | 92.3000 | 96 | 113 | ||||||
| Total liabilities equity | 59,462.3000 | 60,276.9000 | 67,234.9000 | 42,953 | 41,275 | ||||||
Income Statement
|
2010 US GAAP in mill. USD |
2011 US GAAP in mill. USD |
2012 US GAAP in mill. USD |
2013 US GAAP in mill. USD |
2014 US GAAP in mill. USD |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | 35,167 | 38,851.3000 | 39,873.9000 | 21,848 | 20,247 | ||||||
| Depreciation (total) | - | - | - | 791 | 1,548 | ||||||
| Operating Result | 6,088 | 5,751.9000 | 8,084.5000 | 2,629 | 2,599 | ||||||
| Interest Income | -448 | -444.9000 | -513.2000 | -90 | -73 | ||||||
| Income Before Taxes | 5,713 | 5,198.6000 | 6,262.6000 | 2,521 | 2,518 | ||||||
| Income Taxes | 1,087 | 470.2000 | 299.7000 | 138 | 797 | ||||||
| Minority Interests Profit | - | - | - | - | - | ||||||
| Net Income | 4,626 | 4,728.4000 | 5,962.9000 | 2,576 | 2,284 | ||||||
Per Share
Cash Flow
|
2010 US GAAP in mill. USD |
2011 US GAAP in mill. USD |
2012 US GAAP in mill. USD |
2013 US GAAP in mill. USD |
2014 US GAAP in mill. USD |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow from Operating Activities | 8,736 | 8,970.1000 | 9,314.4000 | 3,324 | 3,675 | ||||||
| Cash Flow from Investing Activities | -12,188.3000 | 260.8000 | -6,081.3000 | -3,929 | -202 | ||||||
| Cash Flow from Financing | -1,087.7000 | -6,023.5000 | 716.1000 | -6,696 | -2,742 | ||||||
| Decrease / Increase in Cash | -5,161 | 3,164.4000 | 3,989.3000 | -7,327 | 588 | ||||||
| Employees | 90,000 | 91,000 | 91,000 | 69,000 | 77,000 | ||||||
